BNTX
Price
$106.72
Change
+$0.58 (+0.55%)
Updated
Jun 27 closing price
Capitalization
25.66B
37 days until earnings call
MRNA
Price
$27.16
Change
-$0.38 (-1.38%)
Updated
Jun 27 closing price
Capitalization
10.5B
33 days until earnings call
Interact to see
Advertisement

BNTX vs MRNA

Header iconBNTX vs MRNA Comparison
Open Charts BNTX vs MRNABanner chart's image
BioNTech SE American Depositary Share
Price$106.72
Change+$0.58 (+0.55%)
Volume$490.57K
Capitalization25.66B
Moderna
Price$27.16
Change-$0.38 (-1.38%)
Volume$11.55M
Capitalization10.5B
BNTX vs MRNA Comparison Chart in %
Loading...
BNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BNTX vs. MRNA commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BNTX is a Buy and MRNA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (BNTX: $106.72 vs. MRNA: $27.16)
Brand notoriety: BNTX: Not notable vs. MRNA: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BNTX: 40% vs. MRNA: 103%
Market capitalization -- BNTX: $25.66B vs. MRNA: $10.5B
BNTX [@Biotechnology] is valued at $25.66B. MRNA’s [@Biotechnology] market capitalization is $10.5B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BNTX’s FA Score shows that 2 FA rating(s) are green whileMRNA’s FA Score has 1 green FA rating(s).

  • BNTX’s FA Score: 2 green, 3 red.
  • MRNA’s FA Score: 1 green, 4 red.
According to our system of comparison, BNTX is a better buy in the long-term than MRNA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BNTX’s TA Score shows that 5 TA indicator(s) are bullish while MRNA’s TA Score has 5 bullish TA indicator(s).

  • BNTX’s TA Score: 5 bullish, 4 bearish.
  • MRNA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, MRNA is a better buy in the short-term than BNTX.

Price Growth

BNTX (@Biotechnology) experienced а +0.18% price change this week, while MRNA (@Biotechnology) price change was +4.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

BNTX is expected to report earnings on Aug 04, 2025.

MRNA is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BNTX($25.7B) has a higher market cap than MRNA($10.5B). BNTX YTD gains are higher at: -6.345 vs. MRNA (-34.680). BNTX has higher annual earnings (EBITDA): -447M vs. MRNA (-3.2B). BNTX has more cash in the bank: 14.1B vs. MRNA (5.98B). BNTX has less debt than MRNA: BNTX (293M) vs MRNA (745M). MRNA has higher revenues than BNTX: MRNA (3.14B) vs BNTX (2.75B).
BNTXMRNABNTX / MRNA
Capitalization25.7B10.5B245%
EBITDA-447M-3.2B14%
Gain YTD-6.345-34.68018%
P/E Ratio161.76N/A-
Revenue2.75B3.14B87%
Total Cash14.1B5.98B236%
Total Debt293M745M39%
FUNDAMENTALS RATINGS
MRNA: Fundamental Ratings
MRNA
OUTLOOK RATING
1..100
61
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BNTXMRNA
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
68%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 3 days ago
77%
Declines
ODDS (%)
Bearish Trend 11 days ago
81%
Bearish Trend 11 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
BNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BETZ23.600.21
+0.90%
Roundhill Sports Betting & iGaming ETF
NRSH21.720.10
+0.48%
Aztlan NA Nearshoring Stk Sel ETF
GJUL38.550.12
+0.31%
FT Vest U.S. Eq Mod Buffr ETF - Jul
LLDR44.44N/A
N/A
Global X Long-Term Treasury Ladder ETF
HYDB47.29-0.04
-0.08%
iShares High Yield Systematic Bond ETF

BNTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BNTX has been loosely correlated with SMMT. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if BNTX jumps, then SMMT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNTX
1D Price
Change %
BNTX100%
+0.55%
SMMT - BNTX
52%
Loosely correlated
-3.15%
TIL - BNTX
51%
Loosely correlated
+3.61%
MRNA - BNTX
50%
Loosely correlated
-1.38%
ARCT - BNTX
48%
Loosely correlated
-7.49%
KYMR - BNTX
47%
Loosely correlated
-3.48%
More

MRNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRNA has been loosely correlated with ARCT. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if MRNA jumps, then ARCT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRNA
1D Price
Change %
MRNA100%
-1.38%
ARCT - MRNA
50%
Loosely correlated
-7.49%
BNTX - MRNA
50%
Loosely correlated
+0.55%
CRSP - MRNA
46%
Loosely correlated
+1.69%
NVAX - MRNA
45%
Loosely correlated
-2.00%
RGNX - MRNA
45%
Loosely correlated
-4.11%
More